-
PROVIDERS
New MRD Medicare Coverage for Select Indications*
*When coverage criteria are met. Additional criteria and exceptions for coverage may apply.
-
LIFE SCIENCES
Register now
UPCOMING WEBINARTranslating data into an actionable R&D strategy
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
07/27/2022
Enhanced biomarker discovery and design
Combining sequencing, analytics, and data licensing with Tempus allows you to uncover new insights across the research and development spectrum. This case study shows how one company made it happen.
-
02/12/2026Beyond the EHR: Building a reliable mortality endpoint for oncology research
Emilie Scherrer, Senior Director and Head of Outcomes Research, explains how Tempus’ validated, composite mortality endpoint overcomes data fragmentation to provide a trustworthy foundation for real-world evidence.
Read more -
02/05/2026Accelerating a phase 1 oncology trial: The TIME Network’s impact on patient enrollment
For life sciences companies, speed and precision are paramount. The ability to efficiently launch a Phase 1 trial and generate early clinical data is fundamental to long-term success. The Tempus TIME Trial Network provides the infrastructure to help achieve these goals.
Read more -
02/05/2026Building the engine to scale data abstraction through AI
Learn how Tempus’ AI engine, built on agentic architectures, transforms unstructured clinical text into analysis-ready real-world data. Tempus AI leaders detail the multi-layered system that ensures speed, scale, and fidelity.
Read more
Assess your cohort’s feasibility with our RWD
Submit your preliminary criteria, and our team will provide a tailored feasibility assessment to help accelerate your research goals.*